tradingkey.logo

麦克森

MCK
查看详细走势图
813.800USD
-1.890-0.23%
收盘 12/12, 16:00美东报价延迟15分钟
100.91B总市值
25.32市盈率 TTM

麦克森

813.800
-1.890-0.23%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.23%

5天

+0.64%

1月

-3.83%

6月

+11.76%

今年开始到现在

+42.79%

1年

+41.23%

查看详细走势图

TradingKey 麦克森股票评分

单位: USD 更新时间: 2025-12-12

操作建议

麦克森当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名6/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价934.03。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

麦克森评分

相关信息

行业排名
6 / 159
全市场排名
36 / 4592
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 18 位分析师
买入
评级
934.031
目标均价
+17.06%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

麦克森亮点

亮点风险
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
行业龙头
公司营业收入处于行业前列,最新年度总收入359.05B美元
业绩高增长
公司营业收入稳步增长,连续3年增长29.76%
高分红
公司属于高分红公司,最新股息支付率10.68%
估值合理
公司最新PE估值25.32,处于3年历史合理位
机构减仓
最新机构持股112.70M股,环比减少1.97%
肯·费雪持仓
明星投资者肯·费雪持仓,最新持仓市值1.74K
活跃度增加
近期活跃度增加,过去20天平均换手率0.19

麦克森新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

麦克森简介

McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
公司代码MCK
公司麦克森
CEOTyler (Brian Scott)
网址https://www.mckesson.com/

常见问题

麦克森(MCK)的当前股价是多少?

麦克森(MCK)的当前股价是 813.800。

麦克森的股票代码是什么?

麦克森的股票代码是MCK。

麦克森股票的52周最高点是多少?

麦克森股票的52周最高点是895.580。

麦克森股票的52周最低点是多少?

麦克森股票的52周最低点是558.130。

麦克森的市值是多少?

麦克森的市值是100.91B。

麦克森的净利润是多少?

麦克森的净利润为3.29B。

现在麦克森(MCK)的股票是买入、持有还是卖出?

根据分析师评级,麦克森(MCK)的总体评级为买入,目标价格为934.031。

麦克森(MCK)股票的每股收益(EPS TTM)是多少

麦克森(MCK)股票的每股收益(EPS TTM)是32.136。
KeyAI